Accessibility
Help
Animation
Accessibility

LabCorp(R) Scheduled to Present at the U.S. Bancorp Piper Jaffray Healthcare Conference

27 January 2004

BURLINGTON, N.C., Jan 27, 2004 /PRNewswire-FirstCall via COMTEX/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that Bradford T. Smith, executive vice president of corporate affairs, is scheduled to speak at the U.S. Bancorp Piper Jaffray Healthcare Conference in New York, NY on January 27, 2004 at 4:30 p.m. Eastern Time. A live audio webcast of the presentation will be available via the Company web site at www.labcorp.com . A replay of the audio webcast will be available through February 27, 2004.

About LabCorp

Laboratory Corporation of America(R) Holdings is a pioneer in commercializing new diagnostic technologies and the first in its industry to embrace genomic testing. With annual revenues of $2.5 billion in 2002, over 24,000 employees nationwide, and more than 200,000 clients, LabCorp offers over 4,000 clinical assays ranging from blood analyses to HIV and genomic testing. LabCorp combines its expertise in innovative clinical testing technology with its Centers of Excellence: The Center for Molecular Biology and Pathology, in Research Triangle Park, NC; National Genetics Institute, Inc. in Los Angeles, CA; ViroMed Laboratories, Inc. based in Minneapolis, MN; The Center for Esoteric Testing in Burlington, NC; and DIANON Systems, Inc. based in Stratford, CT. LabCorp clients include physicians, government agencies, managed care organizations, hospitals, clinical labs, and pharmaceutical companies. To learn more about our growing organization, visit our web site at: www.LabCorp.com .

Each of the above forward-looking statements is subject to change based on various important factors, including without limitation, competitive actions in the marketplace and adverse actions of governmental and other third-party payors. Actual results could differ materially from those suggested by these forward-looking statements. Further information on potential factors that could affect LabCorp's financial results is included in the Company's Form 10-K for the year ended December 31, 2002 and will be included in the Company's form 10-K for the year ended December 31, 2003, when filed.

SOURCE Laboratory Corporation of America Holdings 

Pamela Sherry, +1-336-436-4855, of Laboratory Corporation
of America Holdings or Shareholder Direct, +1-800-LAB-0401,

http://www.labcorp.com